Cobb Stuart
- SEC CIK
- 0001994301
In the past year, 1 open-market sale filing worth $141.4K and no purchases.
Current role at each company
- NGNE Neurogene Inc.Chief Scientific Officeras of Mar 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $141.4K
- 1 filing
- Net
- −$141.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cobb Stuart as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 (view filing) | Mar 13 | 4 days | Cobb StuartChief Scientific Officer | SSale | −6.80K | $20.81 | −$141.4K | −18.2%30.5K after | 3 lots10b5-1 |
| May 15, 2025 (view filing) | May 14 | 1 day | Cobb StuartChief Scientific Officer | SSale | −6.80K | $15.15 | −$103.0K | −24.6%20.8K after | 10b5-1 |